CSTL: Castle Biosciences, Inc. Common Stock Company Profile & Statistics

Castle Biosciences, Inc. Common Stock Profile

About

Castle Biosciences Inc. is a commercial-stage dermatological cancer company. It is focused on providing physicians and patients, clinically actionable genomic information. Castle Biosciences Inc. is based in Texas, United States.

Info & Links

CEO

Derek J. Maetzold

Headquarters

505 S. Friendswood Drive, Suite 401
Friendswood, TX 77546, UNITED STATES

Auditor

KPMG LLP

Share holders

Employees

761

Castle Biosciences, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

1.14B

Enterprise Value

1.07B

Enterprise Value/EBITDA(ttm)

394.13

Price to Earnings Ratio(ttm)

156.20

Price to Sales(ttm)

3.32

Price to Book(mrq)

2.44

Price to Cash(ytd)

39.69

Profitability

Gross Margin(ttm)

79.91%

Operating Margin(ttm)

2.29%

Profit Margin(ttm)

-3.41%

Return on Equity(ttm)

1.73%

Return on Invested Capital(ttm)

-2.82%

Return on Assets(ttm)

1.47%

Income Statement

Revenue(ttm)

343.53M

Revenue Per Share(ttm)

11.77

Gross Profit(ttm)

274.63M

EBITDA(ttm)³

2.71M

Net Income Available to Common(ttm)

-12.24M

Diluted EPS(ttm)

-0.45

Share Statistics

Beta (5Y Monthly)

1.14

52-Week Change

40.72%

S&P 500 52-Week Change

15.37%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

29.19M

Dividend Yield

0.00%

Float⁴

27.29M

% Held by Insiders

6.50%

% Held by Institutions

92.60%

Balance Sheet

Total Cash(mrq)

287.54M

Total Cash Per Share(mrq)

9.85

Total Debt(mrq)

10.39M

Total Debt/Equity(mrq)

2.22%

Current Ratio(mrq)

6.47%

Quick Ratio(mrq)

6.31%

Book Value Per Share(mrq)

16.02

Cash Flow

Operating Cash Flow Per Share(ytd)

1.29

Free Cash Flow(ytd)

8.62M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

CSTL

Castle Biosciences, Inc. Common Stock